These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31151624)

  • 21. Formulation of resveratrol entrapped niosomes for topical use.
    Pando D; Matos M; Gutiérrez G; Pazos C
    Colloids Surf B Biointerfaces; 2015 Apr; 128():398-404. PubMed ID: 25766923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
    Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
    Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20.
    Di Marzio L; Marianecci C; Petrone M; Rinaldi F; Carafa M
    Colloids Surf B Biointerfaces; 2011 Jan; 82(1):18-24. PubMed ID: 20832262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation: in-vitro characterization and in-vivo evaluation.
    Mohsen AM; AbouSamra MM; ElShebiney SA
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1254-1264. PubMed ID: 28330377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Entrapment and release difference resulting from hydrogen bonding interactions in niosome.
    Hao YM; Li K
    Int J Pharm; 2011 Jan; 403(1-2):245-53. PubMed ID: 20971171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and evaluation of a buflomedil hydrochloride niosomal patch for transdermal delivery.
    Akhtar N; Arkvanshi S; Bhattacharya SS; Verma A; Pathak K
    J Liposome Res; 2015 Sep; 25(3):191-201. PubMed ID: 25357198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and characterization of EP-liposomes and Span 40-niosomes.
    Ning M; Guo Y; Pan H; Zong S; Gu Z
    Pharmazie; 2006 Mar; 61(3):208-12. PubMed ID: 16599261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin.
    Ullah S; Shah MR; Shoaib M; Imran M; Elhissi AM; Ahmad F; Ali I; Shah SW
    Drug Deliv; 2016 Nov; 23(9):3480-3491. PubMed ID: 27247018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
    El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
    Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of luciferase plasmid entrapped in cationic bilayer vesicles.
    Manosroi A; Thathang K; Werner RG; Schubert R; Manosroi J
    Int J Pharm; 2008 May; 356(1-2):291-9. PubMed ID: 18281170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical versatility of cationic niosomes derived from amino acid-based surfactants: Skin penetration behavior and controlled drug release.
    Muzzalupo R; Pérez L; Pinazo A; Tavano L
    Int J Pharm; 2017 Aug; 529(1-2):245-252. PubMed ID: 28668583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs.
    Mehta SK; Jindal N
    Colloids Surf B Biointerfaces; 2013 Jan; 101():434-41. PubMed ID: 23010052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomes for the Delivery of Lipopeptide Vaccines.
    Yang J; Azuar A; Toth I; Skwarczynski M
    Methods Mol Biol; 2022; 2412():295-307. PubMed ID: 34918252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterization of bolaform surfactant vesicles.
    Muzzalupo R; Trombino S; Iemma F; Puoci F; La Mesa C; Picci N
    Colloids Surf B Biointerfaces; 2005 Dec; 46(2):78-83. PubMed ID: 16257519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fortification of instant coffee beverages - influence of functional ingredients, packaging material and storage time on physical properties of newly formulated, enriched instant coffee powders.
    Benković M; Srečec S; Špoljarić I; Mršić G; Bauman I
    J Sci Food Agric; 2015 Oct; 95(13):2607-18. PubMed ID: 25377798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth Factor-Loaded Nano-niosomal Gel Formulation and Characterization.
    Moghassemi S; Hadjizadeh A; Hakamivala A; Omidfar K
    AAPS PharmSciTech; 2017 Jan; 18(1):34-41. PubMed ID: 27502406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium.
    Abd-Elbary A; El-laithy HM; Tadros MI
    Int J Pharm; 2008 Jun; 357(1-2):189-98. PubMed ID: 18339494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Characterization of Nanostructured Pharmacosomal Mesophases: An Innovative Delivery System for Bioactive Peptides.
    Rezvani M; Hesari J; Peighambardoust SH; Manconi M; Hamishehkar H
    Adv Pharm Bull; 2018 Nov; 8(4):609-615. PubMed ID: 30607333
    [No Abstract]   [Full Text] [Related]  

  • 39. Skin Transport of Hydrophilic Compound-Loaded PEGylated Lipid Nanocarriers: Comparative Study of Liposomes, Niosomes, and Solid Lipid Nanoparticles.
    Rangsimawong W; Opanasopit P; Rojanarata T; Duangjit S; Ngawhirunpat T
    Biol Pharm Bull; 2016; 39(8):1254-62. PubMed ID: 27476936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
    Bendas ER; Abdullah H; El-Komy MH; Kassem MA
    Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.